Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans
Ana Marin D. Carneiro, … , Dennis L. Murphy, Randy D. Blakely
Ana Marin D. Carneiro, … , Dennis L. Murphy, Randy D. Blakely
Published March 3, 2008
Citation Information: J Clin Invest. 2008;118(4):1544-1552. https://doi.org/10.1172/JCI33374.
View: Text | PDF
Research Article Hematology

Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans

  • Text
  • PDF
Abstract

The essential contribution of the antidepressant-sensitive serotonin (5-HT) transporter SERT (which is encoded by the SLC6A4 gene) to platelet 5-HT stores suggests an important role of this transporter in platelet function. Here, using SERT-deficient mice, we have established a role for constitutive SERT expression in efficient ADP- and thrombin-triggered platelet aggregation. Additionally, using pharmacological blockers of SERT and the vesicular monoamine transporter (VMAT), we have identified a role for ongoing 5-HT release and SERT activity in efficient human platelet aggregation. We have also demonstrated that fibrinogen, an activator of integrin αIIbβ3, enhances SERT activity in human platelets and that integrin αIIbβ3 interacts directly with the C terminus of SERT. Consistent with these findings, knockout mice lacking integrin β3 displayed diminished platelet SERT activity. Conversely, HEK293 cells engineered to express human SERT and an activated form of integrin β3 exhibited enhanced SERT function that coincided with elevated SERT surface expression. Our results support an unsuspected role of αIIbβ3/SERT associations as well as αIIbβ3 activation in control of SERT activity in vivo that may have broad implications for hyperserotonemia, cardiovascular disorders, and autism.

Authors

Ana Marin D. Carneiro, Edwin H. Cook, Dennis L. Murphy, Randy D. Blakely

×

Figure 6

Model for αIIbβ3 regulation of SERT function and 5-HT signaling in platelets.

Options: View larger image (or click on image) Download as PowerPoint
Model for αIIbβ3 regulation of SERT function and 5-HT signaling in plate...
(A) SERT-KO platelets lack intracellular 5-HT stores that can be released upon integrin activation. This absence of granule 5-HT leads to diminished aggregation induced by ADP. (B) Leu33 platelets exhibit low basal 5-HT uptake activity, sufficient to maintain granule stores of 5-HT. Binding of immobilized fibrinogen to αIIbβ3 leads to changes in SERT uptake activity that can enhance granule secretion through serotonylation of small Rho GTPases. The depletion of granule stores by reserpine or inhibition of SERT uptake activity by citalopram diminishes platelet aggregation. (C) Integrin β3 Pro33 isoform enhances SERT uptake activity and membrane expression, leading to elevated platelet 5-HT levels. The molecular mechanism for the Pro33 cells involve enhanced PP1 and basal p38 MAPK phosphorylation levels and consequent altered PP2A pathways.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts